Literature DB >> 6116001

Second respiratory and upper digestive tract cancers after oral cancer.

B S Tepperman, P J Fitzpatrick.   

Abstract

Between 1958 and 1975, 377 patients with squamous cell carcinoma of the floor of the mouth were treated. 123 new cancers (not recurrences) developed in 101 (27%) of these patients after treatment. 82 (67%) were squamous cell carcinomas of the respiratory and upper digestive tracts, one-third of these being in the mouth. These tumors developed at a constant rate of 3.6% per year and led to excess mortality of 5.2% per year. Men with oral cancer have a relative risk of 13.4 for new tumours in the upper respiratory and upper digestive tracts compared with the general population; in females the relative risk for all sites is 82.6. All patients with mouth cancer should thus be examined regularly because of this high risk of new cancers.

Entities:  

Mesh:

Year:  1981        PMID: 6116001     DOI: 10.1016/s0140-6736(81)90938-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  A rare case of simultaneous gastric adenocarcinoma and squamous cell carcinoma of the esophagus in a Peruvian, geriatric, female.

Authors:  Ruben Reider
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

2.  Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Snehal G Patel; Richard B Hayes; Ian Ganly
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

Review 3.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

Review 4.  Current concepts of surveillance and its significance in head and neck cancer.

Authors:  Kapila Manikantan; Raghav C Dwivedi; Suhail I Sayed; K A Pathak; Rehan Kazi
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

Review 5.  Chemoprevention of lung cancer.

Authors:  Edward S Kim; Fadlo R Khuri
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

6.  Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Richard B Hayes; Snehal G Patel; Ian Ganly
Journal:  Cancer Causes Control       Date:  2011-02-15       Impact factor: 2.506

7.  HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.

Authors:  Justin A Bishop; Takenori Ogawa; Xiaofei Chang; Peter B Illei; Edward Gabrielson; Sara I Pai; William H Westra
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

Review 8.  Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients.

Authors:  Chen-Shuan Chung; Li-Jen Liao; Chia-Yun Wu; Wu-Chia Lo; Chen-Hsi Hsieh; Tzong-His Lee; Chao-Yu Liu; Deng-Yu Kuo; Pei-Wei Shueng
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 9.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  The EUROSCAN Study. EUROSCAN Steering Committee.

Authors:  N de Vries; N van Zandwijk; U Pastorino
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.